BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32070395)

  • 1. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
    Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
    Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial.
    Germans MR; Post R; Coert BA; Rinkel GJ; Vandertop WP; Verbaan D
    Trials; 2013 May; 14():143. PubMed ID: 23680226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
    Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Wolfs JFC; De Beer FC; Kieft HH; Nanda D; Van Der Pol B; Roks G; De Beer F; Reichman LJA; Brouwers PJAM; Kwa VIH; Van Der Ree TC; Bienfait HP; Boogaarts HD; Klijn CJ; Visser V; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
    Neurology; 2024 Jun; 102(12):e209169. PubMed ID: 38788175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
    Post R; Germans MR; Tjerkstra MA; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; van de Vlekkert J; Bienfait HP; Boogaarts HD; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
    Lancet; 2021 Jan; 397(10269):112-118. PubMed ID: 33357465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial.
    Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; Van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; Bienfait HP; Boogaarts H; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWM; Vandertop WP; Verbaan D;
    Neurology; 2022 Dec; 99(23):e2605-e2614. PubMed ID: 36266046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study.
    Post R; Germans MR; Boogaarts HD; Ferreira Dias Xavier B; Van den Berg R; Coert BA; Vandertop WP; Verbaan D
    PLoS One; 2019; 14(2):e0211868. PubMed ID: 30730957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
    Güresir E; Lampmann T; Bele S; Czabanka M; Czorlich P; Gempt J; Goldbrunner R; Hurth H; Hermann E; Jabbarli R; Krauthausen M; König R; Lindner D; Malinova V; Meixensberger J; Mielke D; Németh R; Darkwah Oppong M; Pala A; Prinz V; Rashidi A; Roder C; Sandalcioglu IE; Sauvigny T; Schebesch KM; Timmer M; Vajkoczy P; Wessels L; Wild F; Wilhelm C; Wostrack M; Vatter H; Coch C
    Int J Stroke; 2023 Feb; 18(2):242-247. PubMed ID: 35361026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
    Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
    Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
    Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
    Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis.
    Rynkowski CB; Hegele V; Soares PHR; Tonello ML; Petterson L; Gomes FK; Rabinstein AA; Bastos LSL; Turon R; Gonçalves B; Righy C; Bozza FA; Kurtz P
    Neurocrit Care; 2023 Aug; 39(1):191-197. PubMed ID: 37131089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
    Baharoglu MI; Germans MR; Rinkel GJ; Algra A; Vermeulen M; van Gijn J; Roos YB
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD001245. PubMed ID: 23990381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study).
    Heidet M; Amathieu R; Audureau E; Augusto O; Nicolazo de Barmon V; Rialland A; Schmitz D; Pierrang F; Marty J; Chollet-Xémard C; Thirion O; Jacob L
    BMJ Open; 2018 Aug; 8(8):e021943. PubMed ID: 30099397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
    Gathier CS; van den Bergh WM; Slooter AJ;
    Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    CRASH-3 trial collaborators
    Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
    Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
    Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Ultra-early" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid].
    Astrup J
    Ugeskr Laeger; 2006 Mar; 168(11):1107-11. PubMed ID: 16545212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
    Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
    Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.